You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PROSTIN E2 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Prostin E2, and when can generic versions of Prostin E2 launch?

Prostin E2 is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in PROSTIN E2 is dinoprostone. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dinoprostone profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PROSTIN E2?
  • What are the global sales for PROSTIN E2?
  • What is Average Wholesale Price for PROSTIN E2?
Drug patent expirations by year for PROSTIN E2
Drug Prices for PROSTIN E2

See drug prices for PROSTIN E2

Recent Clinical Trials for PROSTIN E2

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Medical Centre MariborPhase 4
Aswan University HospitalN/A
Ministry of Health, SingaporeN/A

See all PROSTIN E2 clinical trials

US Patents and Regulatory Information for PROSTIN E2

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer PROSTIN E2 dinoprostone SUPPOSITORY;VAGINAL 017810-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PROSTIN E2

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer PROSTIN E2 dinoprostone SUPPOSITORY;VAGINAL 017810-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Pfizer PROSTIN E2 dinoprostone SUPPOSITORY;VAGINAL 017810-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PROSTIN E2

See the table below for patents covering PROSTIN E2 around the world.

Country Patent Number Title Estimated Expiration
Philippines 11063 METHOD FOR CONTROLLING THE REPRODUCTIVE CYCLE IN AN OVULATING HUMAN ⤷  Sign Up
Netherlands 7017457 ⤷  Sign Up
Israel 35724 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.